Cargando…

Fatal Hypogammaglobulinemia 3 Years after Rituximab in a Patient with Immune Thrombocytopenia: An Underlying Genetic Predisposition?

We report the case of a young woman who developed, 3 years after stopping Rituximab (RTX) prescribed for immune thrombocytopenia (ITP), a severe immunodeficiency leading to fatal pulmonary Epstein–Barr virus-positive diffuse large B-cell lymphoma. Genetic analysis led us to identify four missense mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viallard, Jean-François, Parrens, Marie, Rieux-Laucat, Frédéric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949674/ https://www.ncbi.nlm.nih.gov/pubmed/31956452 http://dx.doi.org/10.1155/2019/2543038

Ejemplares similares

Rituximab Use and Hypogammaglobulinemia
por: Alhassan, Eaman, et al.
Publicado: (2020)

Antigenic Mimicry in Paraneoplastic Immune Thrombocytopenia
por: Vial, Guillaume, et al.
Publicado: (2019)

Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease
por: Tieu, Joanna, et al.
Publicado: (2021)

Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab
por: Perriguey, Marine, et al.
Publicado: (2021)

Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases
por: Khojah, Amer M., et al.
Publicado: (2019)

Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia
por: Barmettler, Sara, et al.
Publicado: (2018)

Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders
por: Marcinnò, Andrea, et al.
Publicado: (2018)

Is Rituximab-Associated Hypogammaglobulinemia Always Linked to B-Cell Depletion?
por: Damianaki, Anthie, et al.
Publicado: (2022)

Hypogammaglobulinemia Observed One Year after Rituximab Treatment for Idiopathic Thrombocytopenic Purpura
por: Shoukat, Bilal Ahmad, et al.
Publicado: (2018)

Case Report: Persistent Hypogammaglobulinemia More Than 10 Years After Rituximab Given Post-HSCT
por: Luterbacher, Fanny, et al.
Publicado: (2021)

Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody–Associated Diseases
por: Avouac, Alexandre, et al.
Publicado: (2021)

Secondary Hypogammaglobulinemia After Rituximab for Neuromyelitis Optica: A Case Report
por: Farhat, Lara, et al.
Publicado: (2018)

Hypogammaglobulinemia following COVID-19 infection in a patient on maintenance rituximab
por: O’Bryan, Collin, et al.
Publicado: (2021)

Rituximab-associated hypogammaglobulinemia in ANCA-associated vasculitis: Incidence and time course
por: Tariq, Anam, et al.
Publicado: (2022)

The genetic landscape of the FAS pathway deficiencies
por: Magerus, Aude, et al.
Publicado: (2021)

Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITP
por: Georgi, Julia-Annabell, et al.
Publicado: (2023)

PD42 - Is rituximab a trigger for persistent hypogammaglobulinemia in idiopathic nephrotic syndrome?
por: Trujillo, Juan Enrique, et al.
Publicado: (2014)

Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey
por: Zurowska, Aleksandra, et al.
Publicado: (2023)

RASopathies: From germline mutations to somatic and multigenic diseases
por: Riller, Quentin, et al.
Publicado: (2021)

PD-L1 is expressed on human activated naive effector CD4(+) T cells. Regulation by dendritic cells and regulatory CD4(+) T cells
por: Mazerolles, Fabienne, et al.
Publicado: (2021)

Rituximab Prevents Stroke Recurrences in Atypical Chronic Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Dupuy, Henry, et al.
Publicado: (2018)

Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab
por: Besada, Emilio
Publicado: (2016)

Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study
por: Wade, Stefanie D., et al.
Publicado: (2021)

Case report: Persistent hypogammaglobulinemia in thymoma-associated myasthenia gravis: the impact of rituximab or Good's syndrome?
por: Ren, Jingru, et al.
Publicado: (2023)

Persistent Hypogammaglobulinemia after Receiving Rituximab Post-HSCT Is Not Caused by an Intrinsic B Cell Defect
por: Ott de Bruin, Lisa M., et al.
Publicado: (2023)

Rituximab for Children with Immune Thrombocytopenia: A Systematic Review
por: Liang, Yi, et al.
Publicado: (2012)

Response to rituximab in children and adults with immune thrombocytopenia (ITP)
por: Harris, Emily M., et al.
Publicado: (2021)

Rituximab-Induced Hypogammaglobulinemia and Risk of Infection in Neuromyelitis Optica Spectrum Disorders: A 14-Year Real-Life Experience
por: Kim, Su-Hyun, et al.
Publicado: (2022)

Risk Factors and Adverse Events Poorly Predict Infections and Hypogammaglobulinemia in Granulomatosis with Polyangiitis Patients Receiving Rituximab
por: Besada, Emilio
Publicado: (2016)

Scaling the tips of the ALPS
por: Rieux-Laucat, Frédéric, et al.
Publicado: (2021)

Hypogammaglobulinemia with Facial Edema
por: Knight, Adina Kay, et al.
Publicado: (2006)

Rituximab-induced IgG hypogammaglobulinemia in children with nephrotic syndrome and normal pre-treatment IgG values
por: Marzuillo, Pierluigi, et al.
Publicado: (2019)

Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?
por: Lucchini, Elisa, et al.
Publicado: (2019)

Tonsillar granuloma associated with hypogammaglobulinemia
por: Laajala, Aleksi, et al.
Publicado: (2020)

Lymphocytosis, Lymphocytopenia, Hypergammaglobulinemia, and Hypogammaglobulinemia
por: Mims, Martha P.
Publicado: (2018)

COVID-19, plasma, and hypogammaglobulinemia
por: Murphy, Michael F., et al.
Publicado: (2020)

Infection Risk, Mortality, and Hypogammaglobulinemia Prevalence and Associated Factors in Adults Treated with Rituximab: A Tertiary Care Center Experience
por: Alhamadh, Moustafa S., et al.
Publicado: (2023)

Utility of indium-111 platelet scintigraphy for understanding the mechanism of thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia
por: Durand, Pauline, et al.
Publicado: (2023)

Symptomatic hypogammaglobulinemia in infancy and childhood – clinical outcome and in vitro immune responses
por: Kidon, Mona Iancovici, et al.
Publicado: (2004)

Hypogammaglobulinemia factitia- Munchausen syndrome masquerading as common variable immune deficiency
por: Ameratunga, Rohan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dops1q7e1i8eg93pr098ndstvt